REDUCE-IT trial

Study / Research

A highly successful omega-3 trial using 4 grams of EPA (Vascepa), which showed a 25% reduction in cardiovascular events and identified the achieved omega-3 level as the strongest predictor of benefit.

Mentioned in 3 videos

Save the 3 videos on REDUCE-IT trial to your own pod.

Sign up free to keep building your knowledge base on REDUCE-IT trial as more episodes are added.

Get Started Free